Literature DB >> 3073384

The effect of azone on ocular levobunolol absorption: calculating the area under the curve and its standard error using tissue sampling compartments.

D D Tang-Liu1, P J Burke.   

Abstract

Methods of calculating the area under the concentration-time curve and the associated standard error are proposed for studies in which each animal contributes one independent data point to a pool of data. This approach can be used for data analysis in bioequivalence studies employing tissue sampling compartments. Application of this method indicated that an azone-containing ophthalmic formulation of levobunolol did not produce better ocular bioavailability than a formulation containing no penetration enhancer.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3073384     DOI: 10.1023/a:1015997814379

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  Estimation of population characteristics of pharmacokinetic parameters from routine clinical data.

Authors:  L B Sheiner; B Rosenberg; V V Marathe
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

2.  Drug-absorption analysis from pharmacological data. I. Method and confirmation exemplified for the mydriatic drug tropicamide.

Authors:  V F Smolen; R D Schoenwald
Journal:  J Pharm Sci       Date:  1971-01       Impact factor: 3.534

3.  Corneal penetration behavior of beta-blocking agents I: Physiochemical factors.

Authors:  R D Schoenwald; H S Huang
Journal:  J Pharm Sci       Date:  1983-11       Impact factor: 3.534

4.  Preliminary pharmacokinetic model of pilocarpine uptake and distribution in the eye.

Authors:  K J Himmelstein; I Guvenir; T F Patton
Journal:  J Pharm Sci       Date:  1978-05       Impact factor: 3.534

5.  Disposition of levobunolol after an ophthalmic dose to rabbits.

Authors:  D D Tang-Liu; S Liu; J Neff; R Sandri
Journal:  J Pharm Sci       Date:  1987-10       Impact factor: 3.534

6.  Aqueous chamber drug distribution volume measurement in rabbits.

Authors:  J M Conrad; J R Robinson
Journal:  J Pharm Sci       Date:  1977-02       Impact factor: 3.534

7.  Ocular and systemic bioavailability of ophthalmic flurbiprofen.

Authors:  D D Tang-Liu; S S Liu; R J Weinkam
Journal:  J Pharmacokinet Biopharm       Date:  1984-12

8.  Determination of ethoxzolamide in the iris/ciliary body of the rabbit eye by high-performance liquid chromatography: comparison of tissue levels following intravenous and topical administrations.

Authors:  M G Eller; R D Schoenwald
Journal:  J Pharm Sci       Date:  1984-09       Impact factor: 3.534

  8 in total
  6 in total

1.  Establishing bioequivalence in serial sacrifice designs.

Authors:  Martin J Wolfsegger
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-10-12       Impact factor: 2.745

2.  Non-compartmental estimation of pharmacokinetic parameters in serial sampling designs.

Authors:  Martin J Wolfsegger; Thomas Jaki
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-10-22       Impact factor: 2.745

3.  Ocular absorption of Pz-peptide and its effect on the ocular and systemic pharmacokinetics of topically applied drugs in the rabbit.

Authors:  Y B Chung; K Han; A Nishiura; V H Lee
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

Review 4.  Ocular drug delivery. Pharmacokinetic considerations.

Authors:  R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

5.  Ocular pharmacokinetics and pharmacodynamics of phenylephrine and phenylephrine oxazolidine in rabbit eyes.

Authors:  D S Chien; R D Schoenwald
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

6.  Rheological Properties, Dissolution Kinetics, and Ocular Pharmacokinetics of Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38.

Authors:  Megan E Cavet; Shellise Glogowski; Ezra R Lowe; Eric Phillips
Journal:  J Ocul Pharmacol Ther       Date:  2019-03-23       Impact factor: 2.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.